Hedge Fund - Enavate Sciences
Get Email AlertsJames Boylan Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Enavate Sciences |
| Manager | James Boylan |
| Portfolio Value | $327,524,118 |
| Change This QTR | +1.86% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | ZBIO | 3,761,359 | $83,502,170 | 25.49% | |||
| 2. | SION | 2,478,030 | $72,878,862 | 22.25% | |||
| 3. | IMNM | 4,768,583 | $55,840,107 | 17.05% | |||
| 4. | UPB | 2,459,703 | $46,267,013 | 14.13% | |||
| 5. | Bridgebio Oncology Therapeut | 2,626,946 | $30,420,035 | NEW | 9.29% |
Latest 13D & 13G Filings
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2025-10-14 | ||||
| 2025-09-15 | ||||
| 2025-02-18 | ||||
| 2024-10-22 | ||||
| 2024-09-23 |
Hedge Fund Resource Center 
